Bioprinting project searching for partners
Droplet dispensing concept could enable high-speed, high-density, multi-colour printing for diagnostics, tissue engineering and drug discovery.× Bioprinting
Independent tech firm TTP is seeking development and go-to-market partners for FormaJet, a printhead platform designed for true multi-colour bioprinting.
When commercialised, TTP says that FormaJet will enable digital processing and bioprinting of molecules for deposition and dispensing. The technology can be tailored to suit TTPs development partners specific market needs, with an initial demo configuration allowing easy loading of 96 colours from SBS plates. The platform is capable of addressing a broad range of reagent types from proteins, peptides and DNA, to low viscosity polymers, organic chemicals, volatile solvents and solid-loaded materials.
FormaJet has been conceived by a team which pulls together TTPs experience in diagnostics, drug discovery, and droplet-based digital printing. It will use droplet generation and control technology which has been proven in applications ranging from drug delivery to inkjet printing, and features a gentle operation, which removes any risk of thermal shock to the material being processed.
Printheads can be designed to be automation-ready and to work with standard SBS liquid handling workflows. A broad spectrum of applications is possible such diagnostic development and manufacture and 2D, 2.5D and 3D bio printing. It will also bring a unique speed of operation and accuracy to more classical liquid handling areas, such as drug discovery synthesis and screening.
The first variation of TTPs platform is being designed to work with 96 fluids from a monolithic block approximately 8cm of standard well-plate width. It is designed to provide ultra-low dead volume and true digital dispensing deposition at rates of 3000 drops per nozzle per second. It is expected to save time and reagent use in both lab and manufacturing environments, in some cases up to 100-fold, according to TTP.
Dr Giles Sanders, life science at TTP, explained: The launch of our FormaJet platform is a jump in our bioprinting ambition. We expect it to advance our established technology, that can print a broad spectrum of biomolecule materials, to something that address a clear need for increased speed and density of printing, as well as providing a step change in the number of reagents that can be printed at one time.
Rob Day, print technology at TTP, said: There is a gap in the market for multi-colour bioprinting. FormaJet will be the first platform to enable digital non-contact dispensing of many colours in a single small format printhead. We look forward to discussing commercial applications with technology providers in a huge range of applications, from lab research to assay development and manufacture.Tags Bioprinting digital DNA Inkjet printing FormaJet TTP
» Publication Date: 31/07/2017
This project has received funding from the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 745828